[Effects of azelastine on an experimentally-induced acute hepatic failure model].
D000208:Acute Disease; D000818:Animals; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010793:Phthalazines / Q000494:pharmacology / Q000627:therapeutic use*; D011135:Polysaccharides, Bacterial; D011425:Propionibacterium acnes; D011724:Pyridazines / Q000627:therapeutic use*; D013189:SRS-A / Q000037:antagonists & inhibitors
D010793:Phthalazines; D011135:Polysaccharides, Bacterial; D011724:Pyridazines; D013189:SRS-A; C020976:azelastine